Mitochondrial dysfunction and Alzheimer's disease

被引：99
|
作者：
Maruszak, Aleksandra [1 ]
Zekanowski, Cezary [1 ]
机构：
[1] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurodegenerat Disorders, PL-02106 Warsaw, Poland
来源：
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 2011年 / 35卷 / 02期
关键词：
Alzheimer's disease; APOE4; Mitochondrial DNA (mtDNA); Mitochondrial dysfunction; Mitochondrial haplogroups; Oxidative stress; CYTOCHROME-C-OXIDASE; AMYLOID PRECURSOR PROTEIN; KETOGLUTARATE DEHYDROGENASE COMPLEX; OXIDATIVELY MODIFIED PROTEINS; MILD COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E GENOTYPE; OXYGEN SPECIES PRODUCTION; MATERNAL FAMILY-HISTORY; FREE-RADICAL GENERATION; MTDNA CONTROL-REGION;
D O I：
10.1016/j.pnpbp.2010.07.004
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
To date, one of the most discussed hypotheses for Alzheimer's disease (AD) etiology implicates mitochondrial dysfunction and oxidative stress as one of the primary events in the course of AD. In this review we focus on the role of mitochondria and mitochondrial DNA (mtDNA) variation in AD and discuss the rationale for the involvement of mitochondrial abnormalities in AD pathology. We summarize the current data regarding the proteins involved in mitochondrial function and pathology observed in AD, and discuss the role of somatic mutations and mitochondrial haplogroups in AD development. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码：320 / 330
页数：11
相关论文
共 50 条
  • [41] Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease
    Anandatheerthavarada, Hindupur K.
    Devi, Latha
    NEUROSCIENTIST, 2007, 13 (06): : 626 - 638
  • [42] Mitochondrial Dysfunction: Different Routes to Alzheimer's Disease Therapy
    Picone, Pasquale
    Nuzzo, Domenico
    Caruana, Luca
    Scafidi, Valeria
    Di Carlo, Marta
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2014, 2014
  • [43] Mitochondrial dysfunction in Alzheimer's disease: Therapeutic implications of lithium
    Singulani, Monique P.
    De Paula, Vanessa J. R.
    Forlenza, Orestes, V
    NEUROSCIENCE LETTERS, 2021, 760
  • [44] Mitochondrial Dysfunction in Alzheimer's Disease: Opportunities for Drug Development
    Bhatia, Shiveena
    Rawal, Rishi
    Sharma, Pratibha
    Singh, Tanveer
    Singh, Manjinder
    Singh, Varinder
    CURRENT NEUROPHARMACOLOGY, 2022, 20 (04) : 675 - 692
  • [45] Mitochondrial dysfunction as an emerging preclinical concept of Alzheimer's disease
    Rhein, V.
    Baysang, G.
    Meier, F.
    Ozmen, L.
    Bluethmann, H.
    Mueller-Spahn, F.
    Czech, C.
    Goetz, J.
    Eckert, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S92 - S92
  • [46] CoQ10 and Mitochondrial Dysfunction in Alzheimer's Disease
    Fisar, Zdenek
    Hroudova, Jana
    ANTIOXIDANTS, 2024, 13 (02)
  • [47] Peripheral Mitochondrial Dysfunction in Alzheimer's Disease: Focus on Lymphocytes
    Leuner, Kristina
    Schulz, Kathrin
    Schuett, Tanja
    Pantel, Johannes
    Prvulovic, David
    Rhein, Virginie
    Savaskan, Egemen
    Czech, Christian
    Eckert, Anne
    Mueller, Walter E.
    MOLECULAR NEUROBIOLOGY, 2012, 46 (01) : 194 - 204
  • [48] Mitochondrial Dysfunction-A Pharmacological Target in Alzheimer's Disease
    Eckert, Gunter P.
    Renner, Kathrin
    Eckert, Schamim H.
    Eckmann, Janett
    Hagl, Stephanie
    Abdel-Kader, Reham M.
    Kurz, Christopher
    Leuner, Kristina
    Muller, Walter E.
    MOLECULAR NEUROBIOLOGY, 2012, 46 (01) : 136 - 150
  • [49] THE ROLE OF β-AMYLOID AND MITOCHONDRIAL DYSFUNCTION IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE
    Szarka Andras
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2015, 68 (7-8): : 222 - 228
  • [50] Mitochondrial Aβ:: A potential cause of metabolic dysfunction in Alzheimer's disease
    Chen, Xi
    Yan, Shi Du
    IUBMB LIFE, 2006, 58 (12) : 686 - 694
12345